トランスレーショナル再生医療市場：製品タイプ、用途別-2025年～2030年の世界予測

トランスレーショナル再生医療市場の2023年の市場規模は30億1,000万米ドルで、2024年には33億6,000万米ドルに達すると予測され、CAGR 11.48％で成長し、2030年には64億6,000万米ドルに達すると予測されています。

トランスレーショナル再生医療基礎科学からの知見を新規治療や医療処置に転換することで、実験室研究と臨床応用のギャップを埋めることを目指す分野です。神経変性疾患、心臓病、ある種のがんなど、現在治療が困難であったり、十分な治療が行われていない疾患の治療に革命をもたらす可能性があるため、この分野は不可欠です。この分野の必要性は、ヘルスケアのニーズの高まり、人口の高齢化、革新的な医療ソリューションへの需要によって強調されています。その用途は組織工学、幹細胞治療、生体材料など多岐にわたり、最終用途は病院、診療所、研究機関などです。市場成長の主な要因は、技術の進歩、研究開発投資の増加、有利な規制の枠組みです。新たなビジネスチャンスは、患者に特化した治療を活用する個別化医療の開発に見られます。再生療法の精度を高めるための歩行分析システムへの投資は、大きな可能性を秘めています。幹細胞や組織のバイオバンキング・サービスの拡大は、臨床現場での迅速な展開の準備を確実にし、商機をさらに広げます。しかし、この分野は、研究開発コストの高さ、複雑な規制当局の承認、幹細胞利用に関する倫理的懸念など、成長の妨げとなりうる課題に直面しています。遺伝子編集のためのCRISPR技術の進歩や、生産コスト削減のための新たな手法の考案によって、イノベーションがこれらの限界にうまく対処できる可能性があります。バイオテクノロジー企業、学術機関、規制当局が協力することで、より迅速な臨床導入に資するエコシステムが醸成される可能性があります。市場は急速な技術革新によって特徴付けられ、企業は継続的な技術革新を余儀なくされます。再生医療治療の拡張性を高め、現行の治療デリバリーシステムを改善することに注力することで、企業は持続的な成長を遂げることができます。規制の変化を常に把握し、市場に特化した調査に投資することは、障害を克服し、急成長する機会を活用する上で極めて重要です。

市場力学：急速に進化するトランスレーショナル再生医療市場の主要市場インサイトを公開

トランスレーショナル再生医療市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の慢性疾患および遺伝関連疾患の罹患率の増加
  • がんや自閉症などの治療における幹細胞治療の需要の高まり
  • 老人人口の増加とそれに伴う疾患の増加
• 市場抑制要因
  • 治療費の高騰と手術の非効率性
• 市場機会
  • 再生医療による臓器移植の継続的研究
  • 有利な償還政策と技術の進歩
• 市場の課題
  • 厳しい規制と認可のためのコンプライアンス義務化

ポーターの5つの力：トランスレーショナル再生医療市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：トランスレーショナル再生医療市場における外部からの影響の把握

外部マクロ環境要因は、トランスレーショナル再生医療市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析トランスレーショナル再生医療市場における競合情勢の把握

トランスレーショナル再生医療市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックストランスレーショナル再生医療市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、トランスレーショナル再生医療市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨トランスレーショナル再生医療市場における成功への道筋を描く

トランスレーショナル再生医療市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で慢性疾患や遺伝性疾患の発生率が増加
    • がんや自閉症などの病気の治療のための幹細胞療法の需要の高まり
    • 高齢化人口の増加とそれに伴う疾病
  • 抑制要因
    • 治療費の高さと運営の非効率性
  • 機会
    • 再生医療による臓器移植の調査が進行中
    • 有利な償還ポリシーと技術の進歩
  • 課題
    • 承認のための厳格な規制とコンプライアンス義務
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 トランスレーショナル再生医療市場：製品タイプ別

• 細胞ベースの製品
• 遺伝子治療製品
• 組織工学製品

第7章 トランスレーショナル再生医療市場：用途別

• 心臓血管
• 皮膚科
• 糖尿病
• 神経学
• 腫瘍学
• 整形外科

第8章 南北アメリカのトランスレーショナル再生医療市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋のトランスレーショナル再生医療市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカのトランスレーショナル再生医療市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Astellas Pharma Inc.
• Athersys, Inc.
• AVITA Medical
• Axogen Corporation
• Gamida Cell Ltd.
• Integra LifeSciences Corporation
• Isto Biologics
• Medtronic PLC
• Mesoblast Ltd.
• MIMEDX, Inc.
• Novartis AG
• Orthofix Medical Inc.
• Parexel International Corporation
• Spark Therapeutics, Inc.
• Vericel Corporation

LIST OF FIGURES

• FIGURE 1. TRANSLATIONAL REGENERATIVE MEDICINE MARKET RESEARCH PROCESS
• FIGURE 2. TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. TRANSLATIONAL REGENERATIVE MEDICINE MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. TRANSLATIONAL REGENERATIVE MEDICINE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. TRANSLATIONAL REGENERATIVE MEDICINE MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. TRANSLATIONAL REGENERATIVE MEDICINE MARKET DYNAMICS
• TABLE 7. GLOBAL TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY CELL BASED PRODUCT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY GENE THERAPY PRODUCT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY TISSUE ENGINEERED PRODUCT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY ORTHOPEDIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 21. ARGENTINA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 23. BRAZIL TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 24. BRAZIL TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 25. CANADA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 26. CANADA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 27. MEXICO TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 28. MEXICO TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 29. UNITED STATES TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 30. UNITED STATES TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 31. UNITED STATES TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 32. ASIA-PACIFIC TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 33. ASIA-PACIFIC TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. ASIA-PACIFIC TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 35. AUSTRALIA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 36. AUSTRALIA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. CHINA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 38. CHINA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. INDIA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 40. INDIA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 41. INDONESIA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 42. INDONESIA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. JAPAN TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 44. JAPAN TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 45. MALAYSIA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 46. MALAYSIA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. PHILIPPINES TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 48. PHILIPPINES TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. SINGAPORE TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 50. SINGAPORE TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 51. SOUTH KOREA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 52. SOUTH KOREA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 53. TAIWAN TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 54. TAIWAN TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. THAILAND TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 56. THAILAND TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. VIETNAM TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 58. VIETNAM TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 59. EUROPE, MIDDLE EAST & AFRICA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 60. EUROPE, MIDDLE EAST & AFRICA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. EUROPE, MIDDLE EAST & AFRICA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 62. DENMARK TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 63. DENMARK TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. EGYPT TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 65. EGYPT TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 66. FINLAND TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 67. FINLAND TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. FRANCE TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 69. FRANCE TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. GERMANY TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 71. GERMANY TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. ISRAEL TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 73. ISRAEL TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 74. ITALY TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 75. ITALY TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. NETHERLANDS TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 77. NETHERLANDS TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 78. NIGERIA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 79. NIGERIA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. NORWAY TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 81. NORWAY TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. POLAND TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 83. POLAND TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. QATAR TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 85. QATAR TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. RUSSIA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 87. RUSSIA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. SAUDI ARABIA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 89. SAUDI ARABIA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 90. SOUTH AFRICA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 91. SOUTH AFRICA TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. SPAIN TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 93. SPAIN TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 94. SWEDEN TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 95. SWEDEN TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. SWITZERLAND TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 97. SWITZERLAND TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. TURKEY TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 99. TURKEY TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. UNITED ARAB EMIRATES TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 101. UNITED ARAB EMIRATES TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 102. UNITED KINGDOM TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 103. UNITED KINGDOM TRANSLATIONAL REGENERATIVE MEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. TRANSLATIONAL REGENERATIVE MEDICINE MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 105. TRANSLATIONAL REGENERATIVE MEDICINE MARKET, FPNV POSITIONING MATRIX, 2023

The Translational Regenerative Medicine Market was valued at USD 3.01 billion in 2023, expected to reach USD 3.36 billion in 2024, and is projected to grow at a CAGR of 11.48%, to USD 6.46 billion by 2030.

Translational Regenerative Medicine is a field that aims to bridge the gap between laboratory research and clinical application by transforming insights from basic science into novel therapies and medical procedures. It is essential due to its potential to revolutionize the treatment of diseases that are currently incurable or inadequately managed, such as neurodegenerative disorders, heart disease, and certain types of cancer. The necessity for this field is underscored by rising healthcare needs, aging populations, and the demand for innovative medical solutions. Its applications are vast, encompassing tissue engineering, stem cell therapy, and biomaterials, with end-use sectors including hospitals, clinics, and research institutions. Market growth is primarily fueled by technological advancements, increased R&D investments, and favorable regulatory frameworks. Emerging opportunities are found in the development of personalized medicine, which leverages patient-specific treatments. Investment in gait analysis systems to enhance the accuracy of regenerative therapies offers significant potential. The expansion of biobanking services for stem cells and tissues adds another layer of commercial opportunity, ensuring readiness for quick deployment in clinical settings. However, the field faces challenges such as high costs of research and development, complex regulatory approvals, and ethical concerns regarding stem cell use that could hinder growth. Innovations could successfully address these limitations through advancements in CRISPR technology for gene editing or by devising new methods to reduce production costs. Collaborations between biotech firms, academic institutions, and regulatory bodies could foster an ecosystem conducive to faster clinical adoption. The market is characterized by rapid technological change, which compels businesses to continuously innovate. Focusing on enhancing the scalability of regenerative medicine therapies and improving current therapeutic delivery systems can position firms for sustained growth. Staying abreast of regulatory changes and investing in market-specific research will be crucial to overcoming obstacles and leveraging burgeoning opportunities.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Translational Regenerative Medicine Market

The Translational Regenerative Medicine Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing incidence of chronic and genetic related diseases worldwide
  • Upsurge in the demand for stem cell therapy for the treatment of diseases such as cancer and autism
  • Rising geriatric population coupled with associated diseases
• Market Restraints
  • High cost of the treatment and operational inefficiency
• Market Opportunities
  • Ongoing research in the organ transplantation with regenerative medicine
  • Favorable reimbursement policies and technological advancements
• Market Challenges
  • Stringent regulations and compliance mandates for approval

Porter's Five Forces: A Strategic Tool for Navigating the Translational Regenerative Medicine Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Translational Regenerative Medicine Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Translational Regenerative Medicine Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Translational Regenerative Medicine Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Translational Regenerative Medicine Market

A detailed market share analysis in the Translational Regenerative Medicine Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Translational Regenerative Medicine Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Translational Regenerative Medicine Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Translational Regenerative Medicine Market

A strategic analysis of the Translational Regenerative Medicine Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Translational Regenerative Medicine Market, highlighting leading vendors and their innovative profiles. These include Astellas Pharma Inc., Athersys, Inc., AVITA Medical, Axogen Corporation, Gamida Cell Ltd., Integra LifeSciences Corporation, Isto Biologics, Medtronic PLC, Mesoblast Ltd., MIMEDX, Inc., Novartis AG, Orthofix Medical Inc., Parexel International Corporation, Spark Therapeutics, Inc., and Vericel Corporation.

Market Segmentation & Coverage

This research report categorizes the Translational Regenerative Medicine Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product Type, market is studied across Cell Based Product, Gene Therapy Product, and Tissue Engineered Product.
• Based on Application, market is studied across Cardiovascular, Dermatology, Diabetes, Neurology, Oncology, and Orthopedic.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing incidence of chronic and genetic related diseases worldwide
    • 5.1.1.2. Upsurge in the demand for stem cell therapy for the treatment of diseases such as cancer and autism
    • 5.1.1.3. Rising geriatric population coupled with associated diseases
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of the treatment and operational inefficiency
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing research in the organ transplantation with regenerative medicine
    • 5.1.3.2. Favorable reimbursement policies and technological advancements
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent regulations and compliance mandates for approval
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Translational Regenerative Medicine Market, by Product Type

• 6.1. Introduction
• 6.2. Cell Based Product
• 6.3. Gene Therapy Product
• 6.4. Tissue Engineered Product

7. Translational Regenerative Medicine Market, by Application

• 7.1. Introduction
• 7.2. Cardiovascular
• 7.3. Dermatology
• 7.4. Diabetes
• 7.5. Neurology
• 7.6. Oncology
• 7.7. Orthopedic

8. Americas Translational Regenerative Medicine Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Translational Regenerative Medicine Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Translational Regenerative Medicine Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Astellas Pharma Inc.
• 2. Athersys, Inc.
• 3. AVITA Medical
• 4. Axogen Corporation
• 5. Gamida Cell Ltd.
• 6. Integra LifeSciences Corporation
• 7. Isto Biologics
• 8. Medtronic PLC
• 9. Mesoblast Ltd.
• 10. MIMEDX, Inc.
• 11. Novartis AG
• 12. Orthofix Medical Inc.
• 13. Parexel International Corporation
• 14. Spark Therapeutics, Inc.
• 15. Vericel Corporation